8JacobsenP,Andersen S,Rossing K,et al. Dual blockade of the renin-an-giotensin system versus maximal recommended dose of ACE inhibition indiabetic nephropathy[ J]. Kidney Int,2003;63(5) ;]874-80.
9Shoda J,Kanno Y,Suzuki H. A five-year comparison of the renal protec-tive effects of angiotensin-converting enzyme inhibitors and angiotensinreceptor blockers in patients with non-diabetic nephropathy [ J ]. InternMed,2006;45(4) :193-8.
10Crook ED, Preddie DC. Therapeutic controversies in hypertension man-agement :angiotensin converting enzyme ( ACE) inhibitors or angiotensinreceptor blockers in diabetic nephropathy. A case for ACE inhibitors[J]. Ethn Dis,2004;14(4) :S2-14.
